Search results
Dana-Farber posts $62M operating income in 1st half of 2024
Becker’s Hospital Review· 1 day agoBoston-based Dana-Farber Cancer Institute reported a $62 million operating income for the six months ended March 31, up from an operating income of $54.3 ...
Riding for a cause: One Mainer's journey doing the Pan-Mass Challenge
WCSH 6 Portland· 7 days agoAccording to the Dana-Farber Cancer Institute, its cancer hospital was ranked #4 globally—the only...
Portsmouth breast cancer survivor celebrates National Cancer Survivor Month through giving back
Portsmouth Herald via Yahoo News· 2 days agoHer diagnosis was Inflammatory Breast Cancer Stage 3b. You can learn more about her story here. "My...
New Research Links Tattoos to Developing Cancer
Futurism via Yahoo News· 23 hours agoNew research suggests that there may be a link between tattoos and cancer. But the findings have proved controversial, with experts pushing back against...
Pilot Study in JNCCN Explores New Approach for Reducing Anxiety and Improving Quality of Life after...
The Woonsocket Call· 3 days agoResearchers at Brigham and Women's Hospital and Dana-Farber Cancer Institute found significant uptake and scalability in phone-based "PATH" intervention ...
500-plus cyclists expected for annual Bikes Fight Cancer fundraiser
Daily Hampshire Gazette· 19 hours agoKicking off at Tree House Brewing Co., on Saturday, June 15, more than 540 cyclists will be taking a...
Andover and North Andover residents ride to raise money for cancer research
The Eagle-Tribune· 6 days agoCyclists from both towns — 56 in all — will participate in the Pan-Mass Challenge, a bike-a-thon...
Obituaries in Burlington, VT | The Burlington Free Press
The Burlington Free Press· 6 days agoNicholas James Kinney's love of life didn't come to an end with his death. Nicholas passed away on April 17th, 2024, at the age of 44 after a...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoPRESS RELEASE Nature's Scientific Reports publishes an article describing the quantification of novel radio-enhancer AGuIX® developed in brain metastases Confirmation, consistently with already published1 observations, of AGuIX® ability to act
Opinion | An epidemic of scientific fakery threatens to overwhelm publishers
Washington Post· 3 days agoAdam Marcus, editorial director for primary care at Medscape, and Ivan Oransky, editor in chief of...